Roundtable Discussion: Platelet Function Testing - Efficacy and Safety of Antiplatelet Agents
Published: 09 July 2015
-
Views:
126
-
Likes:
7
-
Views:
126
-
Likes:
7
-
Part 2 SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES Robert F Storey, Guillaume Taylor, Jeff Dahlen
-
Part 3 SESSION 3: PLATELET REACTIVITY TESTING – TREATMENT OPTIONS FOR HIGH-RISK PCI PATIENTS Robert F Storey, Jean-Philippe Collet, Antonio Colombo, Jeff Dahlen
Overview
During ESC 2013 (NL), Radcliffe Cardiology, in association with the Interventional Cardiology Review journal, filmed a roundtable discussion entitled 'Balancing the Efficacy and Safety of Antiplatelet Agents'.
The discussion was moderated by Robert Storey, (Sheffield, UK). He was joined by expert group of physicians including Jean-Philippe Collet, (Paris, FR), Antonio Colombo, (Milan, IT), Jeff Daheln, (Accumetrics, US), Guillaume Taylor, (Paris, FR) and Stavros Spiliopoulos, (Rion, GR).
The meeting comprised of four multidisciplinary panel discussions on a range of topical issues related to antiplatelet therapy and platelet function testing
Target Audience
This educational activity is intended for an international audience, specifically:
- Interventional Cardiologists
- Interventional Radiologists
- Aligned healthcare professional involved with antiplatelet therapy
Key Learning Objectives
Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:
- Increase physician awareness of the multidisciplinary role of antiplatelet therapy
- Increase understanding of the role of platelet function testing in high-risk PCI
- Explain the emerging role of PFT in PAD
- Assess the role of antiplatelets in neuro-endovascular procedures
More from this programme
Part 1
SESSION 1
Part 2
SESSION 2
Part 3
SESSION 3
Part 4
SESSION 4
Part 5